Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Oren Froy

doi:10.2337/dci19-0061

Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Oren Froy^*

^*Corresponding author for this work

Institute of Biochemistry, Food Science and Nutrition

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	E13-E14
Journal	Diabetes Care
Volume	43
Issue number	1
DOIs	https://doi.org/10.2337/dci19-0061
State	Published - 1 Jan 2020

Bibliographical note

Funding Information:
Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dci19-0061

Cite this

@article{b0d3dd34587e46399f0aa6f35cd72b05,

title = "Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180",

author = "Oren Froy",

note = "Funding Information: Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.",

year = "2020",

month = jan,

day = "1",

doi = "10.2337/dci19-0061",

language = "אנגלית",

volume = "43",

pages = "E13--E14",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "1",

}

TY - JOUR

T1 - Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet

T2 - A randomized clinical trial. Diabetes care 2019;42:2171-2180

AU - Froy, Oren

N1 - Funding Information: Funding. Funding was received from the Israeli Ministry of Health (grant no. 3-00000-12856). Duality of Interest. No potential conflicts of interest relevant to this article were reported.

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85077025171&partnerID=8YFLogxK

U2 - 10.2337/dci19-0061

DO - 10.2337/dci19-0061

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31862829

AN - SCOPUS:85077025171

SN - 0149-5992

VL - 43

SP - E13-E14

JO - Diabetes Care

JF - Diabetes Care

IS - 1

ER -

Reduction in glycated hemoglobin and daily insulin dose alongside circadian clock upregulation in patients with type 2 diabetes consuming a three-meal diet: A randomized clinical trial. Diabetes care 2019;42:2171-2180

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this